Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Blasenkarzinom im Alter

Le carcinome vésical chez les personnes âgées

  • 4 Accesses

This is a preview of subscription content, log in to check access.

Abb. 1
Abb. 2

Literatur

  1. 1.

    Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (Hrsg) (2019) SEER Cancer Statistics Review, 1975–2016. National Cancer Institute, Bethesda (https://seer.cancer.gov/csr/1975_2016/)

  2. 2.

    https://seer.cancer.gov/explorer. Zugegriffen: 01.01.2020

  3. 3.

    Babjuk M, Burger M, Comperat EM, Gontero P, Mostafid AH, Palou J et al (2019) European Association of Urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ) – 2019 update. Eur Urol 76:639–657

  4. 4.

    Herr HW, Donat SM, Reuter VE (2007) Management of low grade papillary bladder tumors. J Urol 178:1201–1205 (discussion 5)

  5. 5.

    Chou R, Selph S, Buckley DI, Fu R, Griffin JC, Grusing S et al (2017) Comparative effectiveness of fluorescent versus white light cystoscopy for initial diagnosis or surveillance of bladder cancer on clinical outcomes: systematic review and meta-analysis. J Urol 197:548–558

  6. 6.

    Margel D, Alkhateeb SS, Finelli A, Fleshner N (2011) Diminished efficacy of Bacille Calmette-Guerin among elderly patients with nonmuscle invasive bladder cancer. Urology 78:848–854

  7. 7.

    Spencer BA, McBride RB, Hershman DL, Buono D, Herr HW, Benson MC et al (2013) Adjuvant intravesical Bacillus Calmette-Guerin therapy and survival among elderly patients with non-muscle-invasive bladder cancer. J Oncol Pract 9:92–98

  8. 8.

    Schiffmann J, Gandaglia G, Larcher A, Sun M, Tian Z, Shariat SF et al (2014) Contemporary 90-day mortality rates after radical cystectomy in the elderly. Eur J Surg Oncol 40:1738–1745

  9. 9.

    Soria F, Moschini M, D’Andrea D, Abufaraj M, Foerster B, Mathieu R et al (2018) Comparative effectiveness in perioperative outcomes of robotic versus open radical cystectomy: results from a multicenter contemporary retrospective cohort study. Eur Urol Focus. https://doi.org/10.1016/j.euf.2018.11.002

  10. 10.

    Ali AS, Hayes MC, Birch B, Dudderidge T, Somani BK (2015) Health related quality of life (HRQoL) after cystectomy: comparison between orthotopic neobladder and ileal conduit diversion. Eur J Surg Oncol 41:295–299

  11. 11.

    Longo N, Imbimbo C, Fusco F, Ficarra V, Mangiapia F, Di Lorenzo G et al (2016) Complications and quality of life in elderly patients with several comorbidities undergoing cutaneous ureterostomy with single stoma or ileal conduit after radical cystectomy. BJU Int 118:521–526

  12. 12.

    Mathieu R, Lucca I, Klatte T, Babjuk M, Shariat SF (2015) Trimodal therapy for invasive bladder cancer: is it really equal to radical cystectomy? Curr Opin Urol 25:476–482

  13. 13.

    Hurria A, Cirrincione CT, Muss HB, Kornblith AB, Barry W, Artz AS et al (2011) Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401. J Clin Oncol 29:1290–1296

  14. 14.

    Aziz A, May M, Burger M, Palisaar RJ, Trinh QD, Fritsche HM et al (2014) Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort. Eur Urol 66:156–163

  15. 15.

    Bilimoria KY, Liu Y, Paruch JL, Zhou L, Kmiecik TE, Ko CY et al (2013) Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons. J Am Coll Surg. https://doi.org/10.1016/j.jamcollsurg.2013.07.385

Download references

Author information

Correspondence to Dr. med. Beat Förster.

Ethics declarations

Interessenkonflikt

B. Förster gibt an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden vom Autor keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Additional information

Hinweis des Verlags

Der Verlag bleibt in Hinblick auf geografische Zuordnungen und Gebietsbezeichnungen in veröffentlichten Karten und Institutsadressen neutral.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Förster, B. Blasenkarzinom im Alter. Urol. Prax. 22, 15–18 (2020). https://doi.org/10.1007/s41973-020-00085-z

Download citation